health
CADL Slips Despite Encouraging Prostate Cancer Drug Data — Retail Believes Stock Is ‘Clearly A Buy And Hold’
Candel’s experimental therapy combined with radiation therapy improved outcomes in patients with localized prostate cancer
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Childhood Obesity: How Can It Be Avoided?
Newswise
WHO Reports Latest Global Trends in Cholera, Meningitis and Plague
The Indian Practitioner
Can Infections Cause Cancer? Lancet Study Links 1 In 8 Cancer Cases To Viruses
NDTV
India has PET-CT machines-So why are cancer patients still waiting for reports?
theweek.in
Decaf helps the memory, and caffeine eases anxiety: Coffee study
ThePrint